Predictive Value of Plasma Copeptin for Outcome of Patients with Acute Cerebral Hemorrhage

doi:10.3969/j.issn.1673-5765.2019.05.005

Abstract

Abstract:

Objective To investigate the predictive value of plasma copeptin in patients with intracranial hemorrhage. Methods Patients with spontaneous cerebral hemorrhage who were hospitalized in Beijing Tian Tan Hospital from January 2011 to May 2012 were consecutively enrolled. Clinical data of patients, such as gender, age, previous history, blood pressure, laboratory test results, imaging information, as well as GCS and NIHSS scores and plama Copeptin levels were collected at admission. The outcome at 30-day and 90-day was assessed by mRS. Logistic regression analysis was used to evaluate the predictive value of plasma copeptin for 30-day mortality and unfavorable prognosis at 90-day. Results A total of 133 patients were included in the study. 9 patients (6.8%) died within 30 days of cerebral hemorrhage. 55 patients (41.4%) had unfavorable functional prognosis at 90-day followup. Baseline hematoma volume (OR 1.06, 95%CI 1.00-1.13, P =0.047) and NIHSS score (OR 1.21, 95%CI 1.05-1.39, P =0.01) were independent predictors of poor prognosis at 90 days after intracerebral hemorrhage. GCS score (OR 1.41, 95%CI 1.21-1.63, P =0.03) and plasma Copeptin level (OR 2.50, 95%CI 1.16-5.37, P =0.02) were independent predictors of 30-day mortality after intracerebral hemorrhage. Conclusions Increased plasma copeptin level is an independent predictive factor of 30-day mortality in patients with spontaneous cerebral hemorrhage.

Key words: Copeptin; Intracerebral hemorrhage; Outcomes

摘要：

目的研究血浆和肽素水平对脑出血患者临床结局的预测价值。方法连续入组2011年1月-2012年5月期间住院的自发性脑出血患者，并收集患者的性别、年龄、既往史及血压、实验室检查、影像学检查信息等。入院时进行GCS评分及NIHSS评分，检测血浆和肽素水平。随访患者30 d生存情况及90 d功能预后（mRS评分）。应用Logi sti c回归分析上述因素对急性脑出血患者30 d死亡及90 d预后不良（mRS评分≤3分）的预测价值。结果共有133例患者纳入研究。9例（6.8%）患者在脑出血后30 d内死亡。在90 d随访期内，55例（41.4%）患者功能预后不良。基线期血肿体积（OR 1.06，95%CI 1.00～1.13，P =0.047）及NIHSS评分（OR 1.21，95%CI 1.05～1.39，P =0.01）是脑出血90 d预后不良的独立预测因素，基线GCS评分（OR 1.41， 95%CI 1.21～1.63，P =0.03）及血浆和肽素水平（OR 2.50，95%CI 1.16～5.37，P =0.02）是脑出血患者 30 d内死亡的独立预测因素。结论血浆和肽素水平高是脑出血短期死亡的独立预测因素。

关键词: 和肽素; 脑出血; 预后

WANG Jing,BIAN Li-Heng, WANG Wen-Juan, LIU Yan-Fang, ZHAO Xing-Quan. Predictive Value of Plasma Copeptin for Outcome of Patients with Acute Cerebral Hemorrhage[J]. Chinese Journal of Stroke, 2019, 14(05): 427-431.

王晶，边立衡，王文娟，刘艳芳，赵性泉. 血浆和肽素水平对急性脑出血患者临床结局的预测研究[J]. 中国卒中杂志, 2019, 14(05): 427-431.

References

[1] CHARIDIMOU A，MOROTTI A，VALENTI R，et al.

Journal Club：time trends in incidence，case fatality，and

mortality of intracerebral hemorrhage[J/OL]. Neurology，

2016，86（20）：e206-e209. https：//doi.org/10.1212/

WNL.0000000000002678.

[2] NAKAMURA K，VELHO G，BOUBY N. Vasopressin

and metabolic disorders：translation from experimental

models to clinical use[J]. J Intern Med，2017，282（4）：

298-309.

[3] CHRIST-CRAIN M，FENSKE W. Copeptin in the

diagnosis of vasopressin-dependent disorders of fluid

homeostasis[J]. Nat Rev Endocrinol，2016，12（3）：168-

176.

[4] MORGENTHALER N G，STRUCK J，ALONSO C，et

al. Assay for the measurement of copeptin，a stable

peptide derived from the precursor of vasopressin[J].

Clin Chem，2006，52（1）：112-119.

[5] SIMS C A，GUAN Y，BERGEY M，et al. Arginine

vasopressin，copeptin，and the development of relative

AVP deficiency in hemorrhagic shock[J]. Am J Surg，

2017，214（4）：589-595.

[6] BATTISTA S，AUDISIO U，GALLUZZO C，et al.

Assessment of diagnostic and prognostic role of copeptin

in the clinical setting of sepsis[J/OL]. Biomed Res Int，

2016：3 624 730. https：//doi.org/10.1155/2016/3624730.

[7] ZHONG Y，WANG R，YAN L，et al. Copeptin in

heart failure：review and meta-analysis[J/OL]. Clin

Chim Acta，2017，475：36-43. https：//doi.org/10.1016/

j.cca.2017.10.001.

[8] GREISENEGGER S，SEGAL H C，BURGESS A I，et

al. Copeptin and long-term risk of recurrent vascular

events after transient ischemic attack and ischemic

stroke：Population-based study[J]. Stroke，2015，46（11）：

3117-3123.

[9] XU Q，TIAN Y，PENG H，et al. Copeptin as a biomarker

for prediction of prognosis of acute ischemic stroke and

transient ischemic attack：a meta-analysis[J]. Hypertens

Res，2017，40（5）：465-471.

[10] TANG W Z，WANG X B，LI H T，et al. Serum copeptin

predicts severity and recurrent stroke in ischemic stroke

patients. Neurotox Res，2017，32（3）：420-425.

[11] CORDONNIER C，DEMCHUK A，ZIAI W，et al.

Intracerebral haemorrhage：current approaches to acute

management[J]. Lancet，2018，392（10 154）：1257-1268.

[12] 中国高血压防治指南修订委员会. 中国高血压防治指南

2010[J]. 中华心血管病杂志，2011，39（7）：579-616.

[13] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南

（2017年版）[J]. 中华糖尿病杂志，2018，10（1）：4-67.

[14] 中国成人血脂异常防治指南修订联合委员会. 中国成人

血脂异常防治指南（2016年修订版）[J]. 中华健康管理

学杂志，2017，11（1）：7-28.

[15] OHMAN E M，BHATT D L，STEG P G，et al. The

REduction of Atherothrombosis for Continued Health

（REACH）Registry：an international，prospective，

observational investigation in subjects at risk for

atherothrombotic events-study design[J]. Am Heart J，

2006，151（4）：786.

[16] SANTAMARÍA A，OLIVER A，BORRELL M，et

al. Risk of ischemic stroke associated with functional

thrombin-activatable fibrinolysis inhibitor plasma

levels[J]. Stroke，2003，34（10）：2387-2391.

[17] GLUSHAKOVA O Y，GLUSHAKOV A V，MILLER E R，

et al. Biomarkers for acute diagnosis and management of

stroke in neurointensive care units[J]. Brain Circ，2016，

2（1）：28-47.

[18] DELGADO P，ALVAREZ-SABIN J，ABILLEIRA S，et

al. Plasma d-dimer predicts poor outcome after acute

intracerebral hemorrhage[J]. Neurology，2006，67（1）：

94-98.

[19] RENDEVSKI V，ALEKSOVSKI B，STOJANOV D，et

al. Peripheral glutamate and TNF-αlevels in patients

with intracerebral hemorrhage：their prognostic values

and interactions toward the formation of the edemal

volume[J]. Neurol Neurochir Pol，2018，52（2）：207-214.

[20] HOWE M D，ZHU L，SANSING L H，et al. Serum

markers of blood-brain barrier remodeling and fibrosis

as predictors of etiology and clinicoradiologic outcome

in intracerebral hemorrhage[J/OL]. Front Neurol，2018，9：

746. https：//doi.org/10.3389/fneur.2018.00746.

[21] LATTUCA B，SY V，NGUYEN L S，et al. Copeptin as

a prognostic biomarker in acute myocardial infarction[J/

OL]. Int J Cardiol，2019，274：337-341. https：//doi.

org/10.1016/j.ijcard.2018.09.022.

[22] ZHANG R，LIU J，ZHANG Y，et al. Association

between circulating copeptin level and mortality risk

in patients with intracerebral hemorrhage：A systemic

review and meta-analysis[J]. Molecular neurobiology，

2017，54：169-174.

[23] ZWEIFEL C，KATAN M，SCHUETZ P，et al. Copeptin

is associated with mortality and outcome in patients with

acute intracerebral hemorrhage[J/OL]. BMC neurol. 2010，

10：34. https：//doi.org/10.1186/1471-2377-10-34.

[24] DONG X Q，HUANG M，YU W H，et al. Change in

plasma copeptin level after acute spontaneous basal

ganglia hemorrhage[J]. Peptides，2011，32（2）：253-257.